Omega-3 fatty acids decreased irritability of patients with bipolar disorder in an add-on, open label study

Nutrition Journal

Volumn 4, Issue , 2005, Pages

  Sagduyu, Kemal ^a   Dokucu, Mehmet E ^b   Eddy, Bruce A ^c   Craigen, Gerald ^d   Baldassano, Claudia F ^e   Yildiz, Ayşegül ^f  

^a UNIVERSITY OF MISSOURI KANSAS CITY   (United States)

^b WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF MISSOURI KANSAS CITY SCHOOL OF MEDICINE   (United States)

^d TORONTO WESTERN HOSPITAL   (Canada)

^e UNIVERSITY OF PENNSYLVANIA   (United States)

^f DOKUZ EYLUL UNIVERSITY   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

OMEGA 3 FATTY ACID;

ARTICLE; BIPOLAR DISORDER; CLINICAL ARTICLE; DISEASE SEVERITY; HEALTH STATUS; HUMAN; IRRITABILITY; PSYCHOTHERAPY; RATING SCALE;

BIPOLAR DISORDER; BODY WEIGHT; FATTY ACIDS, OMEGA-3; FISH OILS; HUMANS; IRRITABLE MOOD; TIME FACTORS;

EID: 15244350377     PISSN: 14752891     EISSN: 14752891     Source Type: Journal    
DOI: 10.1186/1475-2891-4-6     Document Type: Article

References (24)

1. Peet M, Murphy B, Shay J, Horrobin D: Depletion of omega-3 fatty acid levels in red blood cell membranes of depressive patients. Biol Psychiatry 1998, 43(5):315-319.
2. Lake J: Omega-3 Fatty Acids: Theory, Clinical Trials and Safety Issues. Psychiatric Times 2002, 19(10):28-34.
3. Nemets B, Stahl Z, Belmaker RH: Addition of omega-3 fatty acid to maintenance medication treatment for recurrent unipolar depressive disorder. Am J Psychiatry 2002, 159(3):477-479.
4. Hamazaki T, Sawazaki S, Itomura M, Asaoka E, Nagao Y, Nishimura N, Yazawa K, Kuwamori T, Kobayashi M: The effect of docosahexaenoic acid on aggression in young adults. A placebo-controlled double-blind study. J Clin Invest 1996, 97(4):1129-1133.
5. Deckersbach T, Perlis RH, Frankle WG, Gray SM, Grandin L, Dougherty DD, Nierenberg AA, Sachs GS: Presence of irritability during depressive episodes in bipolar disorder. CNS Spectr 2004, 9(3):227-231.
6. Marangell LB, Martinez JM, Zboyan HA, Kertz B, Kim HF, Puryear LJ: A double-blind, placebo-controlled study of the omega-3 fatty acid docosahexaenoic acid in the treatment of major depression. Am J Psychiatry 2003, 160(5):996-998.
7. Keck PE, McElroy SL, Freeman MP: Randomized, placebo-controlled trial of eicosapentaenoic acid in bipolar depression. Bipolar Disord 2003, 5(suppl 1):58.
8. Keck PE, McElroy SL, Freeman MP: Randomized, placebo-controlled trial of eicosapentaenoic acid in rapid cycling bipolar disorder. Bipolar Disord 2003, 5(suppl 1):58.
9. Stoll AL, Severus WE, Freeman MP, Rueter S, Zboyan HA, Diamond E, Cress KK, Marangell LB: Omega 3 fatty acids in bipolar disorder: a preliminary double-blind, placebo-controlled trial. Arch Gen Psychiatry 1999, 56(5):407-412.
10. Mirakhur A, Craig D, Hart DJ, McLlroy SP, Passmore AP: Behavioural and psychological syndromes in Alzheimer's disease. Int J Geriatr Psychiatry 2004, 19(11):1035-1039.
11. McHichi alami K, Tahiri SM, Moussaoui D, Kadri N: [Assessment of premenstrual dysphoric disorder symptoms: population of women in Casablanca]. Encephale 2002, 28(6 Pt 1):525-530.
12. Zanarini MC, Frankenburg FR: omega-3 Fatty acid treatment of women with borderline personality disorder: a double-blind, placebo-controlled pilot study. Am J Psychiatry 2003, 160(1):167-169.
13. Young GS, Maharaj NJ, Conquer JA: Blood phospholipid fatty acid analysis of adults with and without attention deficit/hyperactivity disorder. Lipids 2004, 39(2):117-123.
14. Hirayama S, Hamazaki T, Terasawa K: Effect of docosahexaenoic acid-containing food administration on symptoms of attention-deficit/ hyperactivity disorder - a placebo-controlled double-blind study. Eur J Clin Nutr 2004, 58(3):467-473.
15. Sagduyu K: Omega-3 Fatty Acids for Irritable Mood? Psychiatric Times 2003, 20(3):9.
16. Diagnostic and Statistical Manual of Mental Disorders, Text Revision. 4th edition. Washington, D.C. , American Psychiatric Association; 2000.
17. Sachs GS, Guille C, McMurrich SL: A clinical monitoring form for mood disorders. Bipolar Disord 2002, 4(5):323-327.
18. Young RC, Biggs JT, Ziegler VE, Meyer DA: A rating scale for mania: reliability, validity and sensitivity. Br J Psychiatry 1978, 133:429-435.
19. Hirashima F, Parow AM, Stoll AL, Demopulos CM, Damico KE, Rohan ML, Eskesen JG, Zuo CS, Cohen BM, Renshaw PF: Omega-3 fatty acid treatment and T(2) whole brain relaxation times in bipolar disorder. Am J Psychiatry 2004, 161(10):1922-1924.
20. Ryback R: Bioelectrical modulators and the cell membrane in psychiatric medicine. Psychopharmacol Bull 2001, 35(4):5-44.
21. Bradbury J, Myers SP, Oliver C: An adaptogenic role for omega-3 fatty acids in stress; a randomised placebo controlled double blind intervention study (pilot)ISRCTN22569553. Nutr J 2004, 3(1):20.
22. Peet M, Horrobin DF: A dose-ranging exploratory study of the effects of ethyl-eicosapentaenoate in patients with persistent schizophrenic symptoms. J Psychiatr Res 2002, 36(1):7-18.
23. Plotnikoff GA: Food as medicine - cost-effective health care? The example of omega-3 fatty acids. Minn Med 2003, 86(11):41-45.
24. Covington MB: Omega-3 fatty acids. Am Fam Physician 2004, 70(1):133-140.